ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,440Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1454

$2.13M Total Retail Price of All Prescriptions

Rank: 9 out of 1454

704 Patients Receiving at Least One Drug in Part D
55%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 704 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 704 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 14,923 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$81 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 908 468 S3 1 7
SIMVASTATIN 646 394 2 1
OMEPRAZOLE 585 248 3 3
FUROSEMIDE 581 369 4 6
AMLODIPINE BESYLATE 546 362 5 2
METFORMIN HCL 545 256 6 8
METOPROLOL TARTRATE 472 326 7 10
LEVOTHYROXINE SODIUM 469 277 8 5
METOPROLOL SUCCINATE 451 322 9 13
DIOVAN HCT 427 211 10 75
ZOLPIDEM TARTRATE 409 189 11 19
CARVEDILOL 391 246 12 24
DIOVAN 375 297 13 40
GABAPENTIN 369 130 14 16
LISINOPRIL 358 236 15 4
NEXIUM 354 174 16 23
LOSARTAN-HYDROCHLOROTHIAZIDE 336 212 17 38
OXYCODONE HCL-ACETAMINOPHEN 322 118 S2 18 93
DONEPEZIL HCL 301 288 19 29
CLONIDINE HCL 295 136 20 49
CLOPIDOGREL 294 201 21 32
SPIRIVA 292 142 22 52
HYDRALAZINE HCL 290 189 23 67
PRAVASTATIN SODIUM 286 174 24 12
CYMBALTA 283 131 25 55
HYDROCHLOROTHIAZIDE 274 190 26 9
PROAIR HFA 268 117 27 56
LOSARTAN POTASSIUM 254 209 28 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 243 148 29 27
ADVAIR DISKUS 234 143 30 47
POTASSIUM CHLORIDE 224 176 31 15
ATENOLOL 223 112 32 18
PLAVIX 220 168 33 45
NAMENDA 219 219 34 48
AZITHROMYCIN 216 100 35 42
TRAMADOL HCL 214 86 36 20
TAMSULOSIN HCL 212 179 37 34
OXYCODONE HCL 199 57 S2 38 80
OXYCODONE-ACETAMINOPHEN 196 76 S2 39 60
CRESTOR 171 71 40 22
ATORVASTATIN CALCIUM 171 129 40 11
SINGULAIR 162 92 42 83
TRAZODONE HCL 160 61 43 50
WARFARIN SODIUM 156 140 44 17
RANITIDINE HCL 152 87 45 43
ENDOCET 151 57 S2 46 137
LANTUS 144 78 47 51
JANUVIA 140 85 48 77
CYCLOBENZAPRINE HCL 137 35 R 49 59
SERTRALINE HCL 132 55 50 26
GLIPIZIDE 131 69 51 62
MIRTAZAPINE 130 86 52 53
PHENYTOIN SODIUM EXTENDED 129 37 53 138
ALLOPURINOL 120 63 54 28
GLIMEPIRIDE 119 85 55 33
LEVETIRACETAM 118 48 56 114
POLYETHYLENE GLYCOL 3350 116 98 57 61
TEKTURNA 116 62 57 263
LEVEMIR FLEXPEN 108 64 59 171
ALENDRONATE SODIUM 108 72 59 35
MELOXICAM 107 41 61 37
RAMIPRIL 102 51 62 66
INSULIN SYRINGE 98 47 63 97
CLOTRIMAZOLE-BETAMETHASONE 96 34 64 166
LEXAPRO 96 75 64 205
LANSOPRAZOLE 95 66 66 140
AMLODIPINE BESYLATE-BENAZEPRIL 94 60 67 65
NOVOLOG FLEXPEN 94 28 67 157
PEN NEEDLE 93 56 69 113
LYRICA 92 16 70 103
MONTELUKAST SODIUM 92 44 70 144
PREDNISONE 91 27 72 36
ESCITALOPRAM OXALATE 90 51 73 78
CARISOPRODOL 89 23 R 74 123
LANTUS SOLOSTAR 89 23 74 79
CLOBETASOL PROPIONATE 88 56 76 274
ACTOS 88 53 76 90
CITALOPRAM HBR 86 39 78 21
PRAMIPEXOLE DIHYDROCHLORIDE 86 45 78 200
PROMETHAZINE HCL 86 35 R 78 82
PAROXETINE HCL 85 68 81 73
VERAPAMIL ER 85 65 81 89
SYMBICORT 85 63 81 143
AVODART 84 68 84 243
BENICAR HCT 84 55 84 240
JANUMET 80 22 86 238
QUETIAPINE FUMARATE 80 58 86 91
FLUOXETINE HCL 79 50 88 72
LEVEMIR 79 60 88 202
RISPERIDONE 78 49 90 86
LOVAZA 76 13 91 172
DIGOXIN 75 49 92 70
COLCRYS 75 54 92 116
VALSARTAN-HYDROCHLOROTHIAZIDE 73 35 94 372
FLUTICASONE PROPIONATE 72 34 95 30
CARBAMAZEPINE 72 0 95 230
CIPROFLOXACIN HCL 71 52 97 64
FENTANYL 71 63 S2 97 104
METOLAZONE 69 52 99 216
LEVOFLOXACIN 69 41 99 95
ZETIA 65 36 101 69
FLUCONAZOLE 64 18 102 160
METHYLPREDNISOLONE 64 36 102 186
ONDANSETRON HCL 64 28 102 264
SYNTHROID 63 43 105 25
PRISTIQ ER 62 12 106 306
HUMALOG 61 35 107 153
AMITRIPTYLINE HCL 61 23 R 107 71
PANTOPRAZOLE SODIUM 60 38 109 31
NOVOLOG 59 43 110 99
DILTIAZEM 24HR CD 59 48 110 76
ENALAPRIL MALEATE 59 25 110 58
DOXAZOSIN MESYLATE 56 53 113 87
CLINDAMYCIN HCL 56 21 113 282
PRADAXA 56 52 113 206
TOPIRAMATE 55 17 116 192
METFORMIN HCL ER 55 20 116 41
EXFORGE HCT 54 0 118 333
TRIAMCINOLONE ACETONIDE 54 19 118 142
PROPRANOLOL HCL 54 0 118 129
VESICARE 53 47 121 199
BENZTROPINE MESYLATE 52 18 R 122 174
ISOSORBIDE MONONITRATE ER 52 45 122 46
BENAZEPRIL HCL 52 38 122 57
VENTOLIN HFA 52 12 122 112
BUPROPION XL 50 12 126 194
SEROQUEL 50 36 126 177
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.